Patents Assigned to DexCom, Inc.
-
Patent number: 11064917Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.Type: GrantFiled: January 28, 2021Date of Patent: July 20, 2021Assignee: DexCom, Inc.Inventors: Peter C. Simpson, James H. Brauker, Mark C. Brister, Paul V. Goode, Jr., Apurv Ullas Kamath, Aarthi Mahalingam, Jack Pryor, Matthew D. Wightlin
-
Patent number: 11058329Abstract: Sensor systems can be used to measure an analyte concentration. Sensor systems can include a base having a distal side configured to face towards a person's skin. An adhesive can couple the base to the skin. A transcutaneous analyte measurement sensor can be coupled to the base and can be located at least partially in the host. A transmitter can be coupled to the base and can transmit analyte measurement data to a remote device.Type: GrantFiled: October 30, 2017Date of Patent: July 13, 2021Assignee: DexCom, Inc.Inventors: Peter C. Simpson, Minglian Shi, Sebastian Bohm, Maria Noel Brown Wells, John Patrick Majewski, Leah Morta Edra, Disha B. Sheth, John Michael Gray, Shanger Wang, Ted Tang Lee, Michael L. Moore, Jason Mitchell, Jennifer Blackwell, Neel Narayan Shah, Todd Andrew Newhouse, Jason Halac, Ryan Everett Schoonmaker, Paul V. Neale, Jiong Zou, Sean T. Saint
-
Patent number: 11055198Abstract: Disclosed are systems, methods, and articles for determining compatibility of a mobile application and operating system on a mobile device. In some aspects, a method includes receiving one or more data values from a mobile device having a mobile medical software application installed thereon, the data value(s) characterizing a version of the software application, a version of an operating system installed on the mobile device, and one or more attributes of the mobile device; determining whether the mobile medical software application is compatible with the operating system by at least comparing the received data value(s) to one or more test values in a configuration file; and sending a message to the mobile device based on the determining, the message causing the software application to operate in one or more of a normal mode, a safe mode, and a non-operational mode.Type: GrantFiled: December 27, 2019Date of Patent: July 6, 2021Assignee: DexCom, Inc.Inventors: Issa Sami Salameh, Douglas William Burnette, Tifo Vu Hoang, Steven David King, Stephen M. Madigan, Michael Robert Mensinger, Andrew Attila Pal, Michael Ranen Tyler
-
Patent number: 11051731Abstract: Systems and methods are disclosed which provide for a “factory-calibrated” sensor. In doing so, the systems and methods include predictive prospective modeling of sensor behavior, and also include predictive modeling of physiology. With these two correction factors, a consistent determination of sensitivity can be achieved, thus achieving factory calibration.Type: GrantFiled: June 24, 2020Date of Patent: July 6, 2021Assignee: DexCom, Inc.Inventors: Rui Ma, Naresh C. Bhavaraju, Thomas Stuart Hamilton, Jonathan Hughes, Jeff Jackson, David I-Chun Lee, Peter C. Simpson, Stephen J. Vanslyke
-
Patent number: 11051726Abstract: Systems and methods for processing sensor analyte data are disclosed, including initiating calibration, updating calibration, evaluating clinical acceptability of reference and sensor analyte data, and evaluating the quality of sensor calibration. The sensor can be calibrated using a calibration set of one or more matched sensor and reference analyte data pairs. Reference data resulting from benchtop testing an analyte sensor prior to its insertion can be used to provide initial calibration of the sensor data. Reference data from a short term continuous analyte sensor implanted in a user can be used to initially calibrate or update sensor data from a long term continuous analyte sensor.Type: GrantFiled: January 28, 2021Date of Patent: July 6, 2021Assignee: DexCom, Inc.Inventors: Apurv Ullas Kamath, Jack Pryor, Paul V. Goode, Jr., James H. Brauker, Aarthi Mahalingam
-
Patent number: 11045120Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.Type: GrantFiled: January 28, 2021Date of Patent: June 29, 2021Assignee: DexCom, Inc.Inventors: Peter C. Simpson, James H. Brauker, Mark C. Brister, Paul V. Goode, Jr., Victor Ha, Apurv Ullas Kamath, Aarthi Mahalingam, Steve Masterson, Melissa A. Nicholas, John Nolting, James R. Petisce, Jack Pryor, Sean Saint, Vance Swanson, Matthew D. Wightlin, Kum Ming Woo
-
Patent number: 11044537Abstract: Systems, devices, and methods are disclosed for wireless communication of analyte data. In this regard, in embodiments, a mobile includes a transceiver configured to transmit and receive wireless signals. The mobile device includes circuitry operatively coupled to the transceiver. The mobile device also includes a non-transitory computer-readable medium operatively coupled to the circuitry and storing instructions that, when executed, cause the mobile device to perform a number of operations. One such operation is to obtain a derivative of a first signal received via a first link. Another such operation is to obtain a derivative of a second signal received via a second link; and. Yet another such operation is to generate a selection for connection to an analyte sensor system, based on a comparison of the derivative of the first signal and the derivative of the second signal.Type: GrantFiled: October 12, 2017Date of Patent: June 22, 2021Assignee: DexCom, Inc.Inventors: Aditya Mandapaka, Douglas William Burnette, Hari Hampapuram, Francis William Pascual, James Stephen Amidei, Darin Edward Chum Dew, Apurv Ullas Kamath, Nathanael Paul, William A. Pender, Michael A. Ploof
-
Patent number: 11026605Abstract: The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.Type: GrantFiled: January 28, 2021Date of Patent: June 8, 2021Assignee: DexCom, Inc.Inventors: Peter C. Simpson, James H. Brauker, Mark C. Brister, Paul V. Goode, Jr., Victor Ha, Apurv Ullas Kamath, Aarthi Mahalingam, Steve Masterson, Melissa A. Nicholas, John Nolting, James R. Petisce, Jack Pryor, Sean Saint, Vance Swanson, Matthew D. Wightlin, Kum Ming Woo
-
Patent number: 11032855Abstract: Systems, devices, and methods are disclosed for wireless communication of analyte data. In this regard, in embodiments, a mobile includes a transceiver configured to transmit and receive wireless signals. The mobile device includes circuitry operatively coupled to the transceiver. The mobile device also includes a non-transitory computer-readable medium operatively coupled to the circuitry and storing instructions that, when executed, cause the mobile device to perform a number of operations. One such operation is to obtain a derivative of a first signal received via a first link. Another such operation is to obtain a derivative of a second signal received via a second link; and. Yet another such operation is to generate a selection for connection to an analyte sensor system, based on a comparison of the derivative of the first signal and the derivative of the second signal.Type: GrantFiled: October 12, 2017Date of Patent: June 8, 2021Assignee: DexCom, Inc.Inventors: Aditya Mandapaka, Douglas William Burnette, Hari Hampapuram, Francis William Pascual, James Stephen Amidei, Darin Edward Chum Dew, Apurv Ullas Kamath, Nathanael Paul, William A. Pender, Michael A. Ploof
-
Patent number: 11026640Abstract: Systems and methods for providing sensitive and specific alarms indicative of glycemic condition are provided herein. In an embodiment, a method of processing sensor data by a continuous analyte sensor includes: evaluating sensor data using a first function to determine whether a real time glucose value meets a first threshold; evaluating sensor data using a second function to determine whether a predicted glucose value meets a second threshold; activating a hypoglycemic indicator if either the first threshold is met or if the second threshold is predicted to be met; and providing an output based on the activated hypoglycemic indicator.Type: GrantFiled: January 25, 2021Date of Patent: June 8, 2021Assignee: DexCom, Inc.Inventors: Hari Hampapuram, Anna Leigh Davis, Naresh C. Bhavaraju, Apurv Ullas Kamath, Claudio Cobelli, Giovanni Sparacino, Andrea Facchinetti, Chiara Zecchin
-
Patent number: 11020031Abstract: Systems and methods of use for continuous analyte measurement of a host's vascular system are provided. In some embodiments, a continuous glucose measurement system includes a vascular access device, a sensor and sensor electronics, the system being configured for insertion into communication with a host's circulatory system.Type: GrantFiled: December 23, 2020Date of Patent: June 1, 2021Assignee: DexCom, Inc.Inventors: Peter C. Simpson, Ying Li, Apurv Ullas Kamath, Richard C. Yang
-
Patent number: 11020026Abstract: Membrane systems incorporating silicone polymers are described for use in implantable analyte sensors. Some layers of the membrane system may comprise a blend of a silicone polymer with a hydrophilic polymer, for example, a triblock poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) polymer. Such polymeric blends provide for both high oxygen solubility and aqueous analyte solubility.Type: GrantFiled: July 18, 2018Date of Patent: June 1, 2021Assignee: DexCom, Inc.Inventors: Robert J. Boock, Monica Rixman Swinney
-
Patent number: 11019411Abstract: Systems, devices, and methods are disclosed for wireless communication of analyte data. In this regard, in embodiments, a mobile includes a transceiver configured to transmit and receive wireless signals. The mobile device includes circuitry operatively coupled to the transceiver. The mobile device also includes a non-transitory computer-readable medium operatively coupled to the circuitry and storing instructions that, when executed, cause the mobile device to perform a number of operations. One such operation is to obtain a derivative of a first signal received via a first link. Another such operation is to obtain a derivative of a second signal received via a second link; and. Yet another such operation is to generate a selection for connection to an analyte sensor system, based on a comparison of the derivative of the first signal and the derivative of the second signal.Type: GrantFiled: October 12, 2017Date of Patent: May 25, 2021Assignee: DexCom, Inc.Inventors: Aditya Mandapaka, Douglas William Burnette, Hari Hampapuram, Francis William Pascual, James Stephen Amidei, Darin Edward Chum Dew, Apurv Ullas Kamath, Nathanael Paul, William A. Pender, Michael A. Ploof
-
Patent number: 11017900Abstract: Methods and apparatus, including computer program products, are provided for processing analyte data. In some exemplary implementations, there is provided a method that includes generating, by at least one processor, a data structure comprising a plurality of bins assigned to a plurality of predetermined glucose concentration levels; generating, by the at least one processor, a value representative of a measured glucose concentration level obtained from received sensor data; adding, by the at least one processor, the value to at least one of the plurality of bins, wherein the adding of the value increments an occurrence value for the at least one of the plurality of bins; and analyzing, by the at least one processor, the data structure including the at least one of the plurality of bins and the occurrence value to determine at least one descriptive measurement. Related systems, methods, and articles of manufacture are also disclosed.Type: GrantFiled: June 11, 2019Date of Patent: May 25, 2021Assignee: DexCom, Inc.Inventors: Adam R. Greene, Justin E. Schumacher, Daniel N. Root
-
Patent number: 11006903Abstract: Systems and methods for providing sensitive and specific alarms indicative of glycemic condition are provided herein. In an embodiment, a method of processing sensor data by a continuous analyte sensor includes: evaluating sensor data using a first function to determine whether a real time glucose value meets a first threshold; evaluating sensor data using a second function to determine whether a predicted glucose value meets a second threshold; activating a hypoglycemic indicator if either the first threshold is met or if the second threshold is predicted to be met; and providing an output based on the activated hypoglycemic indicator.Type: GrantFiled: December 26, 2019Date of Patent: May 18, 2021Assignee: DexCom, Inc.Inventors: Hari Hampapuram, Anna Leigh Davis, Naresh C. Bhavaraju, Apurv Ullas Kamath, Claudio Cobelli, Giovanni Sparacino, Andrea Facchinetti, Chiara Zecchin
-
Patent number: 11006829Abstract: Systems, devices, and methods are disclosed for wireless communication of analyte data. One such method includes, during a first interval, establishing a first connection between an analyte sensor system and a display device. During the first connection, the method includes exchanging information related to authentication between the analyte sensor system and the display device. The method includes making a determination regarding whether authentication was performed during the first interval. During a second interval, the method may include establishing a second connection between the analyte sensor system and the display device for transmission of an encrypted analyte value, and bypassing the exchanging of information related to authentication performed during the first connection.Type: GrantFiled: January 15, 2021Date of Patent: May 18, 2021Assignee: DexCom, Inc.Inventors: Aditya Mandapaka, Jorge Valdes, Jeffrey R. Wedekind, Eric Cohen, Douglas William Burnette, Francis William Pascual, Hari Hampapuram, Mark Dervaes, Michael Robert Mensinger
-
Patent number: 11000215Abstract: Systems and methods of use for continuous analyte measurement of a host's vascular system are provided. In some embodiments, a continuous glucose measurement system includes a vascular access device, a sensor and sensor electronics, the system being configured for insertion into communication with a host's circulatory system.Type: GrantFiled: December 23, 2020Date of Patent: May 11, 2021Assignee: DexCom, Inc.Inventors: Peter C. Simpson, Ying Li, Apurv Ullas Kamath, Richard C. Yang
-
Patent number: 11000213Abstract: Systems and methods for processing sensor analyte data are disclosed, including initiating calibration, updating calibration, evaluating clinical acceptability of reference and sensor analyte data, and evaluating the quality of sensor calibration. The sensor can be calibrated using a calibration set of one or more matched sensor and reference analyte data pairs. Reference data resulting from benchtop testing an analyte sensor prior to its insertion can be used to provide initial calibration of the sensor data. Reference data from a short term continuous analyte sensor implanted in a user can be used to initially calibrate or update sensor data from a long term continuous analyte sensor.Type: GrantFiled: October 21, 2020Date of Patent: May 11, 2021Assignee: DexCom, Inc.Inventors: Apurv Ullas Kamath, Jack Pryor, Paul V. Goode, Jr., James H. Brauker, Aarthi Mahalingam
-
Patent number: D926325Type: GrantFiled: December 16, 2019Date of Patent: July 27, 2021Assignee: DexCom, Inc.Inventors: John Charles Barry, Young Woo Lee, David A. Keller, Louise Emma van den Heuvel, Carol Wood Sutherland, John Stanley Hayes
-
Patent number: D926326Type: GrantFiled: June 4, 2020Date of Patent: July 27, 2021Assignee: DexCom, Inc.Inventors: Warren Terry, Patrick John Castagna, David A. Keller, Young Woo Lee, Joseph J. Baker, Randall Scott Koplin, Andrew Joncich